Company Profile
XOMA Corporation Stock Price, News & Analysis
- Ticker:
- XOMA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
40.17 USD (-9.16%)
Close
Last updated: July 13, 2026 at 00:00
781.75M USD
Market cap
Why the stock is moving
XOMA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
XOMA is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, XOMA is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
XOMA follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, XOMA sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
XOMA Royalty Announces Closing of Its Acquisition by Ligand
Source: XOMA Corporation
- 02
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 03
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 04
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of XOMA Corporation (XOMA)?
XOMA Corporation (XOMA) most recently closed at 40.17 USD, a -9.16% move versus the previous session.
What is the market cap of XOMA Corporation (XOMA)?
XOMA Corporation currently has a market capitalization of 781.75M USD on BioPharmSignal.
What does XOMA Corporation do?
XOMA is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is XOMA stock listed?
XOMA Corporation (XOMA) is associated with NASDAQ, United States, Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is XOMA Corporation targeting with Investors?
XOMA is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.